ADC Therapeutics SA
NYSE:ADCT
ADC Therapeutics SA
Net Issuance of Common Stock
ADC Therapeutics SA
Net Issuance of Common Stock Peer Comparison
Competitive Net Issuance of Common Stock Analysis
Latest Figures & CAGR of Competitors
Company | Net Issuance of Common Stock | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
ADC Therapeutics SA
NYSE:ADCT
|
Net Issuance of Common Stock
$5.9m
|
CAGR 3-Years
-76%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
AC Immune SA
NASDAQ:ACIU
|
Net Issuance of Common Stock
CHf43.8m
|
CAGR 3-Years
579%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
N/A
|
|
CRISPR Therapeutics AG
NASDAQ:CRSP
|
Net Issuance of Common Stock
$62.7m
|
CAGR 3-Years
-60%
|
CAGR 5-Years
-28%
|
CAGR 10-Years
N/A
|
|
Basilea Pharmaceutica AG
SIX:BSLN
|
Net Issuance of Common Stock
CHf2m
|
CAGR 3-Years
-25%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-26%
|
|
Idorsia Ltd
SIX:IDIA
|
Net Issuance of Common Stock
CHf360k
|
CAGR 3-Years
-35%
|
CAGR 5-Years
-42%
|
CAGR 10-Years
N/A
|
|
Kuros Biosciences AG
SIX:KURN
|
Net Issuance of Common Stock
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is ADC Therapeutics SA's Net Issuance of Common Stock?
Net Issuance of Common Stock
5.9m
USD
Based on the financial report for Dec 31, 2023, ADC Therapeutics SA's Net Issuance of Common Stock amounts to 5.9m USD.
What is ADC Therapeutics SA's Net Issuance of Common Stock growth rate?
Net Issuance of Common Stock CAGR 3Y
-76%
Over the last year, the Net Issuance of Common Stock growth was 0%. The average annual Net Issuance of Common Stock growth rates for ADC Therapeutics SA have been -76% over the past three years .